Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories, Inc. Class A Common Stock
(NY:
BIO
)
367.37
-1.95 (-0.53%)
Streaming Delayed Price
Updated: 10:39 AM EDT, Sep 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Rad Laboratories, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
February 15, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Earnings Scheduled For February 15, 2024
↗
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Preview: Bio-Rad Laboratories's Earnings
↗
February 14, 2024
Via
Benzinga
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
January 24, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
↗
January 23, 2024
S&P 500 index surges to new highs, driven by AI, earnings optimism, and Fed rate cuts. Top 10 stocks with significant upside potential for 2024 rally.
Via
Benzinga
Topics
Artificial Intelligence
Economy
Stocks
Earnings Outlook For Bio-Rad Laboratories
↗
October 25, 2023
Via
Benzinga
Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
September 13, 2023
Via
Investor Brand Network
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
January 02, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
↗
December 07, 2023
Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%).
Via
Benzinga
Topics
Stocks
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
↗
November 24, 2023
Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed.
Via
Benzinga
Topics
Stocks
The Latest Analyst Ratings for Bio-Rad Laboratories
↗
August 04, 2023
Via
Benzinga
The Latest Analyst Ratings for Bio-Rad Laboratories
↗
June 16, 2023
Via
Benzinga
Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today?
↗
October 27, 2023
Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncertain pace of the biopharma sector's recovery and the
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 26, 2023
Via
Benzinga
Bio-Rad Reports Third-Quarter 2023 Financial Results
October 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 17, 2023
Via
Benzinga
Death Cross Looms Over Bio-Rad Laboratories Investors
↗
May 24, 2023
Via
Benzinga
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
October 05, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
↗
September 02, 2023
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.
Via
InvestorPlace
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
August 28, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2023 Financial Results
August 03, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
July 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Why Are velo Biosciences Stock Is Trading Higher Today?
↗
July 21, 2023
Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO).
Via
Benzinga
Bio-Rad Announces New Share Repurchase Program
July 20, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Publishes Corporate Sustainability Report for 2022
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
↗
June 16, 2023
Via
Benzinga
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
June 01, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
↗
May 11, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
May 08, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
